NORWALK, Conn.--(BUSINESS WIRE)--The next Congress will have a major impact on the U.S. Food and Drug Administration and the pharmaceuticals industry as a whole. The RPM Report, a Windhover publication, is providing two timely forums to prepare for what lies ahead: the FDA/CMS Summit and a complementary audio conference in the coming weeks.
